Cronos Group share price today

(CRON)

Cronos Group share price is $1.95 & ₹165.70 as on 21 Dec 2024, 2.30 'hrs' IST

$1.95

▲

0.08

(4.28%)

Market is closed - opens 8 PM, 23 Dec 2024

View live Cronos Group share price in Dollar and Rupees. Guide to invest in Cronos Group from India. Also see the sentimental analysis on Indian investors investing in Cronos Group. Get details on the Indian mutual funds that are investing in Cronos Group. Get Analyst recommendations and forecasts along with all the Cronos Group's financials.

Cronos Group share price movements

Today's Low: $1.86
Today's High: $1.97
$1.95
4.62%
Downside
Day's Volatility :5.58%
Upside
1.02%
52 Weeks Low: $1.86
52 Weeks High: $3.14
$1.95
4.62%
Downside
52 Weeks Volatility :40.76%
Upside
37.9%

Cronos Group Returns

Period	Cronos Group Inc	Sector (Health Care)	Index (Russel 2000)
3 Months	-9.3%	-11.1%	0.0%
6 Months	-15.58%	-6.0%	0.0%
1 Year	-2.01%	2.7%	0.0%
3 Years	-53.79%	0.6%	-19.7%

Cronos Group Key Statistics

in dollars & INR

Previous Close	$1.87
Open	$1.87
Today's High	$1.97
Today's Low	$1.86
Market Capitalization	$718.9M
Today's Volume	$1.9M
52 Week High	$3.14
52 Week Low	$1.86
Revenue TTM	$101.8M
EBITDA	$-61.5M
Earnings Per Share (EPS)	$-0.12
Profit Margin	-56.43%
Quarterly Earnings Growth YOY	0.14%
Return On Equity TTM	-5.29%

How to invest in Cronos Group from India?

It is very easy for Indian residents to invest directly in Cronos Group from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Cronos Group stock in both Indian Rupees (INR) and US Dollars (USD). Search for Cronos Group or CRON on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Cronos Group or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Cronos Group shares which would translate to 0.436 fractional shares of Cronos Group as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India , including recognised companies like Cronos Group, in just a few clicks!

Returns in Cronos Group for Indian investors in Rupees

Investment Value

₹1,00,000

Cronos Group investment value today

Current value as on today

₹1,04,206

Returns

₹4,206

(+4.21%)

Returns from Cronos Group Stock

₹2,010 (false-2.01%)

Dollar Returns

₹2,196 (+2.2%)

Indian investors sentiment towards Cronos Group

114%

Period: Sep 21, 2024 to Dec 20, 2024. Change in 30 Days versus previous period

Search volume for Cronos Group on INDmoney from India has grown in the last 30 days as on Dec 21, 2024. 114% more investors are searching Cronos Group in the last 30 days versus the previous period.

Global Institutional Holdings in Cronos Group

Chescapmanager LLC
2.08%
Vanguard Group Inc
1.96%
Tidal Investments LLC.
1.31%
Dimensional Fund Advisors, Inc.
0.69%
Mmcap International Inc. Spc
0.56%
Two Sigma Investments LLC
0.38%

Analyst Recommendation on Cronos Group

Buy

61%Buy

30%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Cronos Group(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Cronos Group

What analysts predicted

Upside of 0.05%

Current:

$1.95

Target:

$1.95

Insights on Cronos Group

Price Movement
In the last 7 days, CRON stock has moved up by 1.0%
Increasing Revenue
Revenue is up for the last 4 quarters, 24.57M → 34.26M (in $), with an average increase of 10.2% per quarter
Increasing Net Profit
Netprofit is up for the last 2 quarters, -8.75M → 8.34M (in $), with an average increase of 204.9% per quarter
CRON vs HLN (1 yr)
In the last 1 year, Haleon Plc Spon Ads has given 18.3% return, outperforming this stock by 16.2%
Price to Sales
ForCRON every $1 of sales, investors are willing to pay $7.3, whereas for Haleon Plc Spon Ads, the investors are paying $4.0 for every $1 of sales.

Cronos Group Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$11.5M	↑ 255.17%
Net Income	$-13.9M	↓ 803.1%
Net Profit Margin	-120.8%	↓ 181.82%

	FY19	Y/Y Change
Revenue	$23.8M	↑ 106.0%
Net Income	$2.5B	↓ 17729.39%
Net Profit Margin	10.3K%	↑ 10459.23%

	FY20	Y/Y Change
Revenue	$46.7M	↑ 96.71%
Net Income	$-74.6M	↓ 103.04%
Net Profit Margin	-159.72%	↓ 10498.15%

	FY21	Y/Y Change
Revenue	$74.4M	↑ 59.32%
Net Income	$-396.7M	↑ 431.63%
Net Profit Margin	-532.95%	↓ 373.23%

	FY22	Y/Y Change
Revenue	$91.9M	↑ 23.47%
Net Income	$-168.7M	↓ 57.47%
Net Profit Margin	-183.6%	↑ 349.35%

	FY23	Y/Y Change
Revenue	$87.2M	↓ 5.07%
Net Income	$-74.0M	↓ 56.17%
Net Profit Margin	-84.78%	↑ 98.82%

	Q2 FY23	Q/Q Change
Revenue	$19.0M	↓ 5.57%
Net Income	$-8.4M	↓ 56.59%
Net Profit Margin	-43.95%	↑ 51.65%

	Q3 FY23	Q/Q Change
Revenue	$33.9M	↑ 78.29%
Net Income	$-1.6M	↓ 80.33%
Net Profit Margin	-4.85%	↑ 39.1%

	Q4 FY23	Q/Q Change
Revenue	$24.6M	↓ 27.53%
Net Income	$-46.0M	↑ 2700.63%
Net Profit Margin	-187.35%	↓ 182.5%

	Q1 FY24	Q/Q Change
Revenue	$25.2M	↑ 2.44%
Net Income	$-2.2M	↓ 95.15%
Net Profit Margin	-8.86%	↑ 178.49%

	Q2 FY24	Q/Q Change
Revenue	$27.8M	↑ 10.25%
Net Income	$-8.8M	↑ 292.52%
Net Profit Margin	-31.55%	↓ 22.69%

	Q3 FY24	Q/Q Change
Revenue	$34.3M	↑ 23.45%
Net Income	$8.3M	↓ 195.34%
Net Profit Margin	24.37%	↑ 55.92%

	FY18	Y/Y Change
Profit	$8.3M	↑ 552.15%

	FY19	Y/Y Change
Profit	$-17.9M	↓ 315.93%

	FY20	Y/Y Change
Profit	$-25.8M	↑ 44.61%

	FY21	Y/Y Change
Profit	$-17.5M	↓ 32.13%

	FY22	Y/Y Change
Profit	$12.0M	↓ 168.26%

	FY23	Y/Y Change
Profit	$11.9M	↓ 0.5%

	Q2 FY23	Q/Q Change
Profit	$3.1M	↑ 30.21%

	Q3 FY23	Q/Q Change
Profit	$4.0M	↑ 28.11%

	Q4 FY23	Q/Q Change
Profit	$1.4M	↓ 64.18%

	Q1 FY24	Q/Q Change
Profit	$3.3M	↑ 135.19%

	Q2 FY24	Q/Q Change
Profit	$5.3M	↑ 57.85%

	Q3 FY24	Q/Q Change
Profit	$3.6M	↓ 31.61%

	FY18	Y/Y Change
Operating Cash Flow	$-7.2M	↑ 62.07%
Investing Cash Flow	$-93.9M	↑ 214.11%
Financing Cash Flow	$113.5M	↑ 185.18%

	FY19	Y/Y Change
Operating Cash Flow	$-130.0M	↑ 1718.19%
Investing Cash Flow	$-603.5M	↑ 542.69%
Financing Cash Flow	$1.9B	↑ 1535.55%

	FY20	Y/Y Change
Operating Cash Flow	$-142.5M	↑ 9.58%
Investing Cash Flow	$20.2M	↓ 103.34%
Financing Cash Flow	$-5.5M	↓ 100.29%

	FY21	Y/Y Change
Operating Cash Flow	$-153.6M	↑ 7.83%
Investing Cash Flow	$-28.9M	↓ 243.41%
Financing Cash Flow	$-13.4M	↑ 145.97%

	FY22	Y/Y Change
Operating Cash Flow	$-88.9M	↓ 42.1%
Investing Cash Flow	$-1.8M	↓ 93.63%
Financing Cash Flow	$-2.9M	↓ 78.45%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-11.8M	↓ 75.31%
Investing Cash Flow	$4.8M	↓ 101.6%
Financing Cash Flow	$-39.0K	↓ 94.75%

Cronos Group Technicals Summary

Sell

Neutral

Buy

Cronos Group is currently in a neutral trading position according to technical analysis indicators.

Cronos Group Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Cronos Group Inc	-4.88%	-15.58%	-2.01%	-53.79%	-72.3%
Neurocrine Biosciences Inc.	8.34%	1.35%	5.43%	59.49%	24.91%
Haleon Plc Spon Ads	1.47%	12.15%	18.9%	30.77%	30.77%
Zoetis Inc.	-6.72%	-4.07%	-15.46%	-31.76%	24.53%
Viatris Inc.	-5.51%	19.58%	17.56%	-5.51%	-23.38%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Cronos Group Inc	NA	NA	NA	-0.31	-0.05	-0.04	NA	2.88
Neurocrine Biosciences Inc.	35.99	35.99	0.32	6.54	0.16	0.12	NA	26.87
Haleon Plc Spon Ads	28.53	28.53	1.73	0.34	0.07	0.04	0.02	1.82
Zoetis Inc.	30.68	30.68	2.6	5.88	0.47	0.15	0.01	11.59
Viatris Inc.	224.4	NA	0.07	2.69	-0.04	0.02	0.04	16.58

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Cronos Group Inc	Buy	$718.9M	-72.3%	NA	-56.43%
Neurocrine Biosciences Inc.	Buy	$13.7B	24.91%	35.99	17.21%
Haleon Plc Spon Ads	Buy	$44.1B	30.77%	28.53	10.75%
Zoetis Inc.	Buy	$73.8B	24.53%	30.68	26.55%
Viatris Inc.	Hold	$14.5B	-23.38%	224.4	-5.87%

About Cronos Group

cronos group is a globally diversified and vertically integrated cannabis company with a presence across four continents. the company operates two wholly-owned canadian licensed producers regulated under health canada’s access to cannabis for medical purposes regulations: peace naturals project inc. (ontario), which was the first non-incumbent medical cannabis license granted by health canada, and original bc ltd. (british columbia), which is based in the okanagan valley. the company has multiple international production and distribution platforms: cronos israel and cronos australia. through an exclusive distribution agreement, cronos also has access to over 12,000 pharmacies in germany as the company focuses on building an international iconic brand portfolio and developing disruptive intellectual property.

Organization	Cronos Group
Employees	356
CEO	Mr. Michael Ryan Gorenstein J.D.
Industry	Health Technology

Management People of Cronos Group

Name	Title
Mr. Michael Ryan Gorenstein J.D.	President, CEO & Chairman
Mr. James Holm	Chief Financial Officer
Mr. Jeffrey David Jacobson	Chief Growth Officer
Ms. Anna Shlimak	Chief Strategy Officer
Mr. James Andrew McGinness III	VP, Controller & Principal Accounting Officer
Mr. Shayne J. Laidlaw	Director of Investor Relations & Strategy
Mr. Terry Gregory-Joseph Doucet	General Counsel & Corporate Secretary
Ms. Shannon Buggy	Senior VP & Global Head of People
Mr. Arye Weigensberg	Senior VP and Head of Research & Development
Mr. Adam Wagner	Senior VP & Head of Cronos Israel

Important FAQs about investing in Cronos Group from India :

What is Cronos Group share price today?

Cronos Group share price today stands at $1.95, Open: $1.87 ; Previous Close: $1.87 ; High: $1.97 ; Low: $1.86 ; 52 Week High: $3.14 ; 52 Week Low: $1.86. The stock opens at $1.87, after a previous close of $1.87. The stock reached a daily high of $1.97 and a low of $1.86, with a 52-week high of $3.14 and a 52-week low of $1.86.

Can Indians buy Cronos Group shares?

Yes, Indians can invest in the Cronos Group (CRON) from India.

With INDmoney, you can buy Cronos Group at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Cronos Group at zero transaction cost.

How can I buy Cronos Group shares from India?

It is very easy to buy Cronos Group from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Cronos Group be purchased?

Yes, you can buy fractional shares of Cronos Group with INDmoney app.

What are the documents required to start investing in Cronos Group stocks?

To start investing in Cronos Group, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.